Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INO-4800 for COVID-19 in adults at high risk of SARS-CoV-2 exposure
PACTR202110626944896Phase 3Unknown
- Sponsor
- Inovio Pharmaceuticals, Inc.
- Start
- Dec 2021
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing INO-4800 with Placebo (2 arms). Status: unknown.
02
Drugs
INO-4800
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202110626944896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202110626944896.